pharmaphorum
DECEMBER 24, 2024
Discover the current status of digitalisation in clinical trials and its impact on the industry. Explore the progress and challenges of moving towards digitised clinical trial processes.
Pharmaceutical Technology
DECEMBER 24, 2024
XBiotech has said it will investigate the results of its rheumatoid arthritis trial after finding irregularities in its Phase II trial.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuroBlog - Aurous Healthcare Clinical Trials blog
DECEMBER 24, 2024
Earlier this year, scientists stumbled upon a potential new treatment for hereditary-patterned baldness, the most common cause of hair loss in both men and women worldwide. It all started with research on a sugar that naturally occurs in the body and helps form DNA: the ‘deoxyribose‘ part of deoxyribonucleic acid.
Pharmaceutical Technology
DECEMBER 24, 2024
This seed funding comes after GEMMABio secured $100m in October through a partnership with Brazilian supplier Fiocruz.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
DECEMBER 24, 2024
Sanofi has moved ahead with plans to challenge Pfizer and MSD for a piece of the market for pneumococcal vaccines.
Pharmaceutical Technology
DECEMBER 24, 2024
RAPT Therapeutics and Shanghai Jemincare Pharmaceutical have signed an exclusive agreement for RPT904 to treat various allergic conditions.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharmaceutical Technology
DECEMBER 24, 2024
The FDA initially rejected the marketing application for Alhemo in 2022, asking for additional data on dosing and monitoring.
pharmaphorum
DECEMBER 24, 2024
The FDA has wrapped up a series of new approvals as 2024 draws to a close, with Novo Nordisk, Pfizer, Vertex, and Hikma among the beneficiaries.
Pharmaceutical Technology
DECEMBER 24, 2024
AstraZeneca has gained approval from the European Commission for its oral therapy, Tagrisso (osimertinib), to treat adults with NSCLC.
pharmaphorum
DECEMBER 24, 2024
AstraZeneca and Daiichi Sankyo have decided to voluntarily withdraw their EU marketing application for Dato-DXd in lung cancer.
Pharmaceutical Commerce
DECEMBER 24, 2024
The latest news for pharma industry insiders.
pharmaphorum
DECEMBER 24, 2024
Explore the latest perspectives on cell therapies for autoimmune disease treatment post-ACR 2024 and how they are transforming therapy options.
Pharmaceutical Commerce
DECEMBER 24, 2024
The Drug Supply Chain Security Act was a major coverage area for Pharma Commerce in 2024.
AuroBlog - Aurous Healthcare Clinical Trials blog
DECEMBER 24, 2024
The World Ayurveda Congress and Arogya Expo 2024 that concluded last Sunday at the Parade Ground in Dehradun generated over 150 million USD in business opportunities. According to the organisers, the move is reflecting on increasing global demand for Ayurvedic medicines and wellness products.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
XTalks
DECEMBER 24, 2024
The pharmaceutical industry continues to heavily invest in TV commercials as its primary mode of advertising. The industry has spent an estimated $6 billion to $8 billion a year on ad spend over the past couple of years. In 2023, the top ten ad spenders spent $2.87 billion on TV ads. As of December 4, 2024, here are the top ten new prescription drug commercials by TV impressions (data from ispot.tv) that dominated television screens in 2024. 1.
Expert insights. Personalized for you.
52 
Let's personalize your content